Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Agranulocytosis | x | x | x | ||
Anorexia | x | x | x | ||
Arthralgia | x | x | x | ||
Asthenia | x | x | x | ||
Ataxia | x | x | |||
Chest pain | x | x | x | ||
Coma | x | x | |||
Confusional state | x | x | x | ||
Constipation | x | x | x | ||
Diarrhoea | x | x | x | ||
Dizziness | x | x | |||
Drowsiness | x | x | |||
Dyspnoea | x | x | x | ||
Rash | x | x | x | ||
Flushing | x | x | x | ||
Hallucination | x | x | x | ||
Headache | x | x | x | ||
Heartburn | x | x | x | ||
Hypotension | x | x | x | ||
Irritability | x | x | x | ||
Lethargy | x | x | |||
Leukopenia | x | x | x | ||
Nausea | x | x | x | ||
Nervousness | x | x | x | ||
Palpitations | x | x | x | ||
Pruritus | x | x | x | ||
Salivary hypersecretion | x | x | x | ||
Withdrawal syndrome | x | ||||
Sweating | x | x | x | ||
Syncope | x | x | x | ||
Vomiting | x | x | x | ||
Dry mouth | x | x | x | ||
Agitation | x | x | x | ||
Phosphatase alkaline increased | x | ||||
Aspartate aminotransferase increased | x | x | x | ||
Lightheadedness | x | x | |||
Disorientation | x | x | |||
Apprehension | x | x | x | ||
Excitement | x | x | |||
Thinking abnormal | x | ||||
Slurred speech | x | x | x | ||
Euphoric mood | x | x | x | ||
Taste bitter | x | x | x | ||
Upset stomach | x | x | x | ||
Drug intolerance | x | x | |||
Anaphylactoid reaction | x | ||||
Vision blurred | x | x | x | ||
Hyperkinesia | x | x | |||
Gastrointestinal pain | x | x | x | ||
Staggering gait | x | x | |||
Talkativeness | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||
---|---|---|---|---|---|
Insomnia | x | x | x | ||
Terminal insomnia | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |